ACHV
Achieve Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$8.49
+2.17%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- -16.3%
- EPS
- -6.2%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- +41.7%
- EPS
- +53.7%
Three-year CAGR
- Revenue
- —
- EBITDA
- -43.2%
- EBIT
- -40.5%
- Net income
- -37.2%
- EPS
- -0.8%
- Free cash flow
- -66.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026